Skip to content
10-K

Annual Report

Boundless Bio, Inc. BOLD

0001193125-26-097543

← back to feed
Filed
Mar 9, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 2, 2026 22.41M sh
Shares Diluted FY 2025 · Dec 31, 2025 22.36M sh
Shares Diluted FY 2025 · Dec 31, 2024 16.98M sh
Capex FY 2025 · Dec 31, 2025 $546K
Capex FY 2025 · Dec 31, 2024 $2.54M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$46.66M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$60.84M
Short Term Investments FY 2025 · Dec 31, 2025 $89.71M
Short Term Investments FY 2025 · Dec 31, 2024 $125.53M
Cash And Equivalents FY 2025 · Dec 31, 2025 $17.87M
Cash And Equivalents FY 2025 · Dec 31, 2024 $26.59M
Stockholders Equity FY 2025 · Dec 31, 2025 $98.65M
Stockholders Equity FY 2025 · Dec 31, 2024 $150.64M
Current Liabilities FY 2025 · Dec 31, 2025 $12.54M
Current Liabilities FY 2025 · Dec 31, 2024 $8.14M
Total Liabilities FY 2025 · Dec 31, 2025 $58.41M
Total Liabilities FY 2025 · Dec 31, 2024 $55.77M
Current Assets FY 2025 · Dec 31, 2025 $109.61M
Current Assets FY 2025 · Dec 31, 2024 $154.39M
Total Assets FY 2025 · Dec 31, 2025 $157.06M
Total Assets FY 2025 · Dec 31, 2024 $206.41M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.60
Eps Diluted FY 2025 · Dec 31, 2024 −$3.85
Eps Basic FY 2025 · Dec 31, 2025 −$2.60
Eps Basic FY 2025 · Dec 31, 2024 −$3.85
Sga Expense FY 2025 · Dec 31, 2025 $18.71M
Sga Expense FY 2025 · Dec 31, 2024 $18M
Rd Expense FY 2025 · Dec 31, 2025 $44.85M
Rd Expense FY 2025 · Dec 31, 2024 $55.27M
Net Income FY 2025 · Dec 31, 2025 −$58.2M
Net Income FY 2025 · Dec 31, 2024 −$65.36M
Operating Income FY 2025 · Dec 31, 2025 −$63.55M
Operating Income FY 2025 · Dec 31, 2024 −$73.27M